The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
739 reports and counting
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Breye Therapeutics Raises €67.5M Series A for Oral Retinal Disease Drugs
Breye Therapeutics raised an over-subscribed €67.5 million Series A co-led by Mission BioCapital and Novo Holdings to advance danegaptide into a Phase 2 trial.
Efficient Computer Announces $97M+ Series B for Energy-Efficient Processors
Efficient Computer said it entered into agreements for more than $97 million in Series B financing at a $650 million valuation, led by TQ Ventures, to ship its Electron E1 processor in volume to lead customers.
Talen Energy Names Terry Nutt Chief Executive Officer
Talen Energy named President Terry Nutt its next CEO effective January 1, 2027, succeeding retiring CEO Mac McFarland, with an emphasis on safe operations, its flywheel strategy and disciplined capital allocation.
Quartermaster Raises $140M in Series B and Debt for Ocean Data Network
Quartermaster raised $140 million, a $100 million Series B led by Insight Partners plus a $40 million Stifel venture debt facility, to build an ocean data network.
Island Raises $400M Series F at $6.4B Valuation
Island raised a $400 million Series F led by Evolution Equity Partners at a $6.4 billion valuation to fuel growth as enterprises scale AI agents.
Claris Bio Relocates Corporate Headquarters to South San Francisco
Claris Bio will relocate its corporate headquarters from Jersey City to South San Francisco in October 2026 as it advances CSB-001.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.